Antithrombotics in vascular disease and renal dysfunction

Journal of the American College of Cardiology

This analysis evaluated whether the benefits of rivaroxaban 2.5 mg bd plus aspirin, comparedwith aspirin alone, are maintained in vascular patients who also have renal dysfunction.

Fracassi F, Crea F, et al.

Volume 73, Issue 18, May 2019

This study examined the prevalence,morphological features, and significance ofhealed plaques at the culprit site in patients withacute coronary syndromes usingoptical coherence tomography.

Cardiac magnetic resonance for cardiac prognostication

This study tested the hypothesis that evidence ofischaemia or infarction on cardiac magnetic resonance imaging provideseffective cardiovascular risk stratification in patientswith chest pain syndromes.

Renal impairment and dabigatran reversal with idarucizumab

This study examined the impact ofrenal impairment on the extent of dabigatran reversalby idarucizumab and on clinical outcomes.